IMA Stock Analysis: Buy, Sell, or Hold?
IMA - ImageneBio, Inc. Common Stock
$5.52
0.11 (2.03%)
▲
5d:
-6.6%
30d:
-8.15%
90d:
-21.14%
HOLD
LOW Confidence
Analysis Updated: May 21, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When IMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMA is currently trading at $5.52, which is considered oversold relative to its 30-day fair value range of $5.55 to $5.97.
Technical Outlook: Technically, IMA is in a strong downtrend. Immediate support is located at $5.10, while resistance sits at $5.97.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.00 (+334.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMA is in a strong downtrend. Immediate support is located at $5.10, while resistance sits at $5.97.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.00 (+334.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.55 -
$5.97
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 334.8% below Wall St target ($24.00)
- CAUTION: Recommendation downgraded due to -6.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$5.55 -
$5.97
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.10
Resistance Level
$5.98
Current Trend
Strong Downtrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.39
Wall Street Target
$24.00
(+334.8%)
Share & Embed Analysis
Last updated: May 21, 2026 10:07 PM ET
Data refreshes hourly during market hours. Next update: 11:07 PM
Data refreshes hourly during market hours. Next update: 11:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Joseph P Slattery
BUY
16000 shares
2025-12-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 60 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 62 BUY |